株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の無針 (ニードルフリー) ドラッグデリバリー市場の展望:2016年〜2026年

Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology

発行 Visiongain Ltd 商品コード 233147
出版日 ページ情報 英文 183 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=148.54円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
世界の無針 (ニードルフリー) ドラッグデリバリー市場の展望:2016年〜2026年 Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology
出版日: 2016年08月25日 ページ情報: 英文 183 Pages
概要

当レポートでは、無針 (ニードルフリー) デリバリーの世界市場について調査分析しており、無針ドラッグデリバリー技術の必要性、メリット・デメリット、有益となる臨床現場、現在利用可能なジェットインジェクターと競合技術/製品の概要、現在開発中のジェットインジェクターと競合技術/製品の概要、ジェットインジェクターと競合製品の売上予測、市場影響因子の分析、専門家の見解などをまとめています。

第1章 レポート概要

第2章 無針 (ニードルフリー) ドラッグデリバリー技術のイントロダクション

  • 無針デリバリー技術とは
    • 針刺し損傷
  • 無針デリバリー技術市場
    • ジェット式注射器
    • 無針技術と競合する技術
  • 無針デリバリー技術が有益となる臨床現場
    • 疼痛管理
    • ワクチンデリバリー
    • 糖尿病患者のためのインスリンデリバリー
    • 小児科における注射
    • その他
  • 無針デリバリー技術市場の規制
    • 米国の規制制度
    • 欧州の規制制度
  • バイオ医薬品
    • イントロダクション
    • 生物製剤:成長中の医薬品市場

第3章 無針ドラッグデリバリー技術の世界市場

  • 無針デリバリー技術市場の概要
  • 無針デリバリー技術市場の区分
  • 無針デリバリー市場の予測
  • 無針デリバリー技術の市場動向
  • 無針デリバリー技術の成長促進要因と抑制要因

第4章 ジェット式注射技術市場

  • ジェット式注射器市場
  • ジェット式注射器市場の予測
  • ジェット式注射器市場の主要製品
  • ジェット式注射器の開発パイプライン

第5章 競合する無針技術市場

  • 競合する無針技術の概要
  • 競合する無針技術市場の予測
  • 将来における市場シェアの変化
  • 新しい針技術の概要
  • 新しい針技術市場の予測
  • 吸入器技術の概要
  • 吸入器技術市場の予測
  • 経皮パッチ技術の概要
  • 経皮パッチ技術市場の予測
  • その他開発中の競合技術

第6章 主要国の無針ドラッグデリバリー市場

  • 世界の無針デリバリー市場:地域別の予測
  • 米国
  • 欧州5カ国
  • 日本
  • 中国
  • インド

第7章 主要企業

  • Antares Pharma
  • Zogenix
  • 3M
  • Becton Dickinson and Company
  • PharmaJet
  • BioJect Medical Technologies

第8章 無針デリバリー市場の定性分析

  • SWOT分析
  • 強み
  • 弱み
  • 機会
  • 脅威

第9章 結論

第10章 用語集

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0139

Title:
NEEDLE-FREE DELIVERY TECHNOLOGY MARKET FORECAST 2016-2026
Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M.

What can be expected from the Needle-Free Delivery Technologies Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.

Our 183-page report provides 105 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national Needle-Free Delivery Technology markets. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects

Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

See revenue forecasts for the leading regional and national markets

How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets, including:

  • US
  • EU5 (Germany, France, UK, Italy and Spain)
  • Japan
  • China
  • India
  • Rest of the World

Leading companies and potential for market growth

Visiongain forecasts overall revenue for the Needle-Free Delivery Technologies Market will reach $2,093.9m in 2020. We predict high revenue growth over the forecast period, which will driven by the strong demand for improved vaccine and drug delivery methods.

Our work analyses the key companies in the market. See visiongain's analysis of six leading companies, including:

  • 3M
  • Antares Pharma
  • Beckton Dickinson and Company (BD)
  • Bioject Medical Technologies
  • PharmaJet
  • Zogenix

A company profile gives you the following information where available:

  • Discussion of a company's activities and outlook including regional and national revenue shares
  • Historic revenue, analysis and discussion of company performance
  • Analysis of major products/services currently available on the market
  • Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the needle-free drug delivery industry?

Our new report discusses issues and events affecting the needle-free delivery technology market. You will find discussions, including qualitative analyses:

  • Highly fragmented and competitive market with significant variations in different geographic regions
  • Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
  • Future opportunities for needle-free delivery technologies

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M report helps you

In summary, our 183-page report gives you the following knowledge:

  • Revenue forecasts to 2026 for the Needle-Free Delivery Technology Market - discover the industry's prospects, finding promising places for investments and revenues
  • Revenue forecasts to 2026 for two major submarkets - jet injectors and competing technologies (novel needle technology, inhaler technology and transdermal patch technology)
  • Revenue forecasts to 2026 for two major regional markets - EU5 and Rest of the World
  • Revenue forecasts to 2026 for the leading national markets - US, Germany, France, UK, Italy, Spain, Japan, China, India and Rest of the World
  • Assessment of leading companies - analysis of services, business operations, products, pipelines, revenue (where available) and recent mergers & acquisition activity
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the needle-free drug delivery market and leading companies. You will find data, trends and predictions. Please order our report now.

visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Needle-Free Delivery Technology Market Overview
  • 1.2. Global Needle-Free Delivery Technology Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who is This Report For?
  • 1.7. Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Introduction to Needle-Free Delivery Technology

  • 2.1. What is Needle-Free Delivery Technology?
    • 2.1.1. Needlestick Injury
      • 2.1.1.1. Blood-Borne Pathogens and Needlestick Injury
      • 2.1.1.2. Accidental Needlestick Injury: A Serious Healthcare Problem
  • 2.2. The Needle-Free Delivery Technology Market
    • 2.2.1. Jet Injectors
      • 2.2.1.1. Concerns about Multi-use Nozzle Jet injectors (MUNJIs)
      • 2.2.1.2. Strengths and Weaknesses of Jet Injectors
    • 2.2.2. Competing Needle-Free Technologies
      • 2.2.2.1. Novel Needle Technology
      • 2.2.2.2. Pen Needles
      • 2.2.2.3. Microneedles
      • 2.2.2.4. Hollow Microneedles
      • 2.2.2.5. Solid Coated Microneedles
      • 2.2.2.6. Solid Biodegradable Microneedles
      • 2.2.2.7. Solid Uncoated Microneedles
      • 2.2.2.8. Using the Right Microneedles
      • 2.2.2.9. Inhaler Technology
      • 2.2.2.10. Transdermal Patch Technology
  • 2.3. Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
    • 2.3.1. Pain Management
      • 2.3.1.1. Using Needle-Free Injection Devices to Administer Lidocaine
    • 2.3.2. Vaccine Delivery: Improving Immune Response
      • 2.3.2.1. Needle-Free Vaccine Delivery
      • 2.3.2.2. Mass Immunisation
    • 2.3.3. Insulin Delivery for Diabetics
    • 2.3.4. Paediatric Injections
    • 2.3.5. Other Uses for Needle-Free Injection Technology
  • 2.4. Regulation of the Needle-Free Delivery Technology Market
    • 2.4.1. The US Regulation System
      • 2.4.1.1. Combination Products
      • 2.4.1.2. FDA Statement Clamps Down On Delivery of Medications in Non-Approved Needle-Free Devices
    • 2.4.2. The European Regulation System
      • 2.4.2.1. Post Marketing Surveillance in the EU
  • 2.5. Biopharmaceuticals
    • 2.5.1. An Introduction to the Biological Drugs Market
    • 2.5.2. Biologics: A Rising Drugs Market

3. Needle-Free Delivery Technology: Global Market 2016-2026

  • 3.1. The Needle-Free Delivery Technology Market: Overview
  • 3.2. Needle-Free Delivery Technology Market Segmentation, 2016
  • 3.3. The Needle-Free Delivery Technology Market Forecast, 2016-2026
  • 3.4. How Will Segmental Market Shares Change to 2026?
  • 3.5. Needle-Free Delivery Technology: Market Trends, 2016-2026
  • 3.6. Needle-Free Delivery Technology: Drivers and Restraints 2016-2026

4. Jet Injectors Technology Market, 2016-2026

  • 4.1. The Jet Injectors Market Overview
  • 4.2. Jet Injectors: Market Forecast 2016-2026
  • 4.3. Jet Injector Devices on the Market
    • 4.3.1. Biojector 2000(Bioject Medical Technologies)
    • 4.3.2. ZetaJet (Bioject Medical Technologies)
    • 4.3.3. Vision (Antares Pharma)
    • 4.3.4. Vibex (Antares Pharma)
    • 4.3.5. Sumavel DosePro (Endo International)
    • 4.3.6. Stratis (PharmaJet)
    • 4.3.7. LectraJet (D'Antonio Consultants International)
    • 4.3.8. AdvantaJet and GentleJet (Activa Brand Products)
    • 4.3.9. Vitajet (Bioject Medical Technologies)
    • 4.3.10. Med-Jet (Medical International Technologies)
    • 4.3.11. J-Tip (National Medical Products)
    • 4.3.12. Injex30(Injex Pharma)
    • 4.3.13. SQ-Pen, SQ-X and MHP-1(Bespak)
    • 4.3.14. E-Jet 100(Eurojet Medical)
    • 4.3.15. Penjet (Penjet Corporation)
  • 4.4. Jet Injectors Development Pipeline
    • 4.4.1. Glide SDI (Glide Pharmaceutical Technologies)
    • 4.4.2. Zeneo (Crossject)
    • 4.4.3. Relday (Zogenix)
    • 4.4.4. Magnetic Injection (Massachusetts Institute of Technology)
    • 4.4.5. Intradermal (ID) Pen (Bioject Medical Technologies)
    • 4.4.6. Iject and Iject R (Bioject Medical Technologies)
    • 4.4.7. Jupiter Jet (Bioject Medical Technologies)

5. Competing Needle-Free Technology Market, 2016-2026

  • 5.1. The Competing Needle-Free Technology Overview
  • 5.2. The Competing Technology: Market Forecast 2016-2026
  • 5.3. How Will Segmental Market Shares Change to 2026?
  • 5.4. Novel Needle Technology Overview
  • 5.5. Novel Needle Technology: Market Forecast, 2016-2026
    • 5.5.1. Leading Novel Needle Technologies
      • 5.5.1.1. Soluvia Microinjection System (BD)
      • 5.5.1.2. Ultra-Fine Nano 4mm Pen Needle (BD)
      • 5.5.1.3. AutoShield Duo Pen Needle (BD)
      • 5.5.1.4. Microstructured Transdermal Systems (3M)
      • 5.5.1.5. ZP Patch Technology (Zosano)
    • 5.5.2. Novel Needle Technology Development Pipeline
      • 5.5.2.1. Microneedle Patch (Georgia Institute of Technology)
      • 5.5.2.2. Micronjet (NanoPass)
      • 5.5.2.3. DebioJect (Debiotech)
      • 5.5.2.4. AdminPen (nanoBioSciences)
      • 5.5.2.5. PKA SoftTouch (PKA SoftTouch Corp)
      • 5.5.2.6. DrugMat and VaxMat (TheraJect)
      • 5.5.2.7. MicroCor (Corium International)
      • 5.5.2.8. Nanopatch (Vaxxas)
      • 5.5.2.9. Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark)
      • 5.5.2.10. Memspatch and Micro-Patch (Nemaura)
      • 5.5.2.11. Microneedle Patch for Lidocaine Delivery (National University of Singapore)
  • 5.6. Inhaler Technology Overview
  • 5.7. Inhaler Technology: Market Forecast, 2016-2026
    • 5.7.1. Inhaler Products in the Asthma Market
      • 5.7.1.1. Preventer Inhalers
      • 5.7.1.2. Reliever Inhalers
    • 5.7.2. Inhaler Products in the Insulin Market
    • 5.7.3. Inhaler Products in the Vaccine Market: FluMist Quadrivalent (MedImmune)
      • 5.7.3.1. Pipeline
  • 5.8. Transdermal Patch Technology Overview
  • 5.9. Transdermal Patch Technology: Market Forecast, 2016-2026
    • 5.9.1. Selected Transdermal Patch Products
      • 5.9.1.1. Duragesic (Fentanyl, Janssen Pharmaceuticals)
      • 5.9.1.2. Nicoderm CQ (Nicotine, GlaxoSmithKline)
      • 5.9.1.3. Exelon Patch (Rivastigmine, Novartis)
      • 5.9.1.4. Zecuity (Sumatriptan, Teva)
    • 5.9.2. Transdermal Patch Technology Development Pipeline
      • 5.9.2.1. Electronic Transdermal Patch (Rhenovia Pharma)
      • 5.9.2.2. Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems)
      • 5.9.2.3. Ultrasonic Waveforms (U-Strip, Transdermal Specialties)
      • 5.9.2.4. Prelude SkinPrep System (Echo Therapeutics)
  • 5.10. Other Competing Needle-free delivery Technology in development
    • 5.10.1. Microbubbles Injection (Shibaura Institute of Technology)
    • 5.10.2. Laser Injection (Seoul National University)
    • 5.10.3. Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
    • 5.10.4. Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)

6. Leading National Markets 2016-2026

  • 6.1. Global Needle-Free Delivery Technology Market: Regional Forecast 2016-2026
    • 6.1.1. How Will Regional Market Shares Change to 2026?
  • 6.2. The US Needle-Free Delivery Technology Market 2016-2026
    • 6.2.1. US Needle-Free Delivery Technology Market Forecast 2016-2026
    • 6.2.2. FDA Guideline for Combination Products
    • 6.2.3. Needle-Free Delivery and the US Flu Vaccination Market
    • 6.2.4. Measles Outbreak in the US
  • 6.3. The EU5 Needle-Free Delivery Technology Market 2016-2026
    • 6.3.1. EU5 Needle-Free Delivery Technology Market Forecast 2016-2026
    • 6.3.2. The German Needle-Free Delivery Technology Market Forecast, 2016-2026
    • 6.3.3. The French Needle-Free Delivery Technology Market Forecast, 2016-2026
    • 6.3.4. The UK Needle-Free Delivery Technology Market Forecast, 2016-2026
    • 6.3.5. The Italian Needle-Free Delivery Technology Market Forecast, 2015-2026
    • 6.3.6. The Spanish Needle-Free Delivery Technology Market Forecast, 2016-2026
  • 6.4. The Japanese Needle-Free Delivery Technology Market 2016-2026
    • 6.4.1. Japanese Needle-Free Delivery Technology Market Forecast 2016-2026
  • 6.5. The Chinese Needle-Free Delivery Technology Market 2016-2026
    • 6.5.1. Chinese Needle-Free Delivery Technology Market Forecast 2016-2026
  • 6.6. The Indian Needle-Free Delivery Technology Market 2016-2026
    • 6.6.1. Indian Needle-Free Delivery Technology Market Forecast 2016-2026
    • 6.6.2. Needles and Syringes being Reused in Indian Hospitals

7. Leading Companies in the Needle-Free Delivery Technology Market

  • 7.1. Leading Needle-Free Delivery Technology Manufacturers in 2015
  • 7.2. Antares Pharma: Leading the Needle-Free Injector Market
    • 7.2.1. Antares Pharma: Needle-Free Technology Product Portfolio
    • 7.2.2. Antares Pharma: Future Outlook
    • 7.2.3. Antares Pharma: Products in Development
    • 7.2.4. Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma
  • 7.3. Zogenix
    • 7.3.1. Zogenix: Product Portfolio
    • 7.3.2. Zogenix: Current Pipeline
    • 7.3.3. Zogenix: Financial Overview
  • 7.4. 3M: 50 Years of Drug Delivery Technology Development
    • 7.4.1. 3M: Drug Delivery Technology Portfolio
      • 7.4.1.1. Oral and Topical Drug Delivery
      • 7.4.1.2. MDI for Nasal and Inhalable Drugs
      • 7.4.1.3. Transdermal patch Technology
      • 7.4.1.4. Microneedle Technology
    • 7.4.2. 3M: Market Outlook
  • 7.5. Becton Dickinson and Company (BD)
    • 7.5.1. BD: Drug Delivery Technology Portfolio
      • 7.5.1.1. Prefillable Syringe Systems
      • 7.5.1.2. Self-Injection Systems
      • 7.5.1.3. Pen Needles
      • 7.5.1.4. Safety & Shielding Systems
    • 7.5.2. BD: Future Outlook
    • 7.5.3. New Infusion Set with BD FlowSmart Technology Cleared by FDA
    • 7.5.4. BD Acquired Injection Safety Firms
    • 7.5.5. Recall of BD Needles in Hong Kong
  • 7.6. PharmaJet
    • 7.6.1. PharmaJet: Needle-Free Delivery Technology Product Portfolio
    • 7.6.2. First FDA Approved Jet Injector for Flu Shot in the US
    • 7.6.3. PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline
    • 7.6.4. Preference for PharmaJet over Needle and Syringe
  • 7.7. BioJect Medical Technologies
    • 7.7.1. Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline
    • 7.7.2. Bioject Medical Technologies: Financial Overview
    • 7.7.3. Focusing on Developing Countries

8. Qualitative Analysis of the Needle-Free Delivery Technology Market

  • 8.1. SWOT Analysis of the Needle-Free Delivery Technology Market
  • 8.2. Strengths
    • 8.2.1. Strong Growth in the Biologic Drug Market
    • 8.2.2. Increasing Development in Transdermal Delivery
    • 8.2.3. No Specialist Training Required and No Needlestick Injuries
    • 8.2.4. Eliminating the Cold Chain Problem
  • 8.3. Weaknesses
    • 8.3.1. Healthcare Practitioners are not Familiar with Novel Delivery Systems
    • 8.3.2. Greater Regulatory Scrutiny
    • 8.3.3. Inefficient Manufacturing Processes
  • 8.4. Opportunities
    • 8.4.1. Emerging Economies Offer Significant Growth Opportunities
    • 8.4.2. Mass Immunisation Programmes around the World
    • 8.4.3. Increasing Global Diabetic Population
    • 8.4.4. Shift towards Home Administration Setting
    • 8.4.5. Extending Life Cycle of Drugs
  • 8.5. Threats
    • 8.5.1. Traditional Needles and Syringes are Very Cheap to Mass Produce
    • 8.5.2. Needle and Syringes with Anti Needlestick Injury Technology
    • 8.5.3. Limited Clinical Data
    • 8.5.4. Medical Device Excise Tax

9. Conclusions

  • 9.1. Current Leading Needle-Free Technology Segments
    • 9.1.1. Notable Needle-Free Technology Companies
    • 9.1.2. Leading Regional Markets
  • 9.2. Global Needle-Free Technology Market Forecast 2015-2026
  • 9.3. The Future of the Needle-Free Technology Market
    • 9.3.1. Biosimilars are a Major Driver of the Needle-free Delivery Market
    • 9.3.2. Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market

10. Glossary

Appendix

  • Visiongain's Bespoke Research Service
  • Some Associated Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Tables

  • Table 2.1: Classification of Jet Injectors by Method of Propulsion
  • Table 2.2: Strengths and Weaknesses of the Jet Injector Market
  • Table 2.3: Pen Needle Technology by Needle Length
  • Table 2.4: Rationale for Needle-Free Vaccine Delivery
  • Table 2.5: Examples of Needle-Free Vaccine Delivery Systems, 2016
  • Table 2.6: Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2016
  • Table 2.7: FDA Guidance on Regulation of Needle-Free Injectors, 2015
  • Table 2.8: Top 5 Biologics by Sales ($bn), 2015
  • Table 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2015
  • Table 3.2: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 3.3: Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2015, 2020 and 2026
  • Table 4.1: The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.1: The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.2: Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2015
  • Table 5.3: Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.4: Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.5: Leading Products in the Asthma Preventer Inhaler Market, 2016
  • Table 5.6: Leading Products in the Asthma Reliever Inhaler Market, 2016
  • Table 5.7: Vaccine Inhalers Currently Under Development, 2016
  • Table 5.8: Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.9: Transdermal Patch Products, 2016
  • Table 6.1: Global Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%) by Region, 2015-2026
  • Table 6.2: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
  • Table 6.3: Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
  • Table 6.4: US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.5: EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.6: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015, 2020 and 2026
  • Table 6.7: German Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.8: French Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.9: UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.10: Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.11: Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.12: Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.13: Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.14: Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 7.1: Antares Pharma: Overview, 2016
  • Table 7.2: Antares Pharma: 2016 Product Portfolio (Product, Drug, Partner, Indication and Territory
  • Table 7.3: Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2014 and 2015
  • Table 7.4: Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2014 and 2015
  • Table 7.5: Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 7.6: Antares Pharma: Products in Development 2016 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status)
  • Table 7.7: Zogenix: Overview, 2016
  • Table 7.8: Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 7.9: Zogenix: Revenue ($m) by Type, 2010-2015
  • Table 7.10: 3M: Overview, 2016
  • Table 7.11: 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 7.12: BD: Overview, 2016
  • Table 7.13: BD: Drug Delivery Products by Segment, 2016
  • Table 7.14: BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
  • Table 7.15: BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 7.16: PharmaJet: Overview, 2016
  • Table 7.17: BioJect Medical Technologies: Overview, 2016
  • Table 7.18: Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
  • Table 7.19: Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 8.1: SWOT Analysis of the Needle-Free Delivery Technology Market, 2016-2026
  • Table 8.2: Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2015

List of Figures

  • Figure 1.1: Global Needle-Free Delivery Technology Market Segmentation Overview, 2015
  • Figure 2.1: Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device
  • Figure 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2015-2026
  • Figure 3.2: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2015
  • Figure 3.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
  • Figure 3.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
  • Figure 3.5: Needle-Free Delivery Technology: Drivers and Restraints 2016-2026
  • Figure 4.1: The Jet Injectors Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.1: The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.2: Market Shares (%) of Competing Needle-Free Technology Market Segments, 2015
  • Figure 5.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
  • Figure 5.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
  • Figure 5.5: Novel Needle Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.6: Inhaler Technology Market: Revenue ($m), AGR (%), 2015-2026
  • Figure 5.7: Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.1: Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
  • Figure 6.2: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2020
  • Figure 6.3: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2020-2026
  • Figure 6.4: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2026
  • Figure 6.5: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
  • Figure 6.6: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2020
  • Figure 6.7: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2026
  • Figure 6.8: US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.9: EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%), 2015-2026
  • Figure 6.10: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015
  • Figure 6.11: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2020
  • Figure 6.12: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2026
  • Figure 6.13: German Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.14: French Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.15: UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.16: Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.17: Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.18: Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.19: Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.20: Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 7.1: Antares Revenue from Major Customers: Revenue Share (%), 2014
  • Figure 7.2: Antares Revenue from Major Customers: Revenue Share (%), 2015
  • Figure 7.3: Antares Revenue by Region: Revenue Share (%), 2014
  • Figure 7.4: Antares Revenue by Region: Revenue Share (%), 2015
  • Figure 7.5: Antares Pharma: Historical Revenue ($m) and AGR (%), 2010-2015
  • Figure 7.6: Zogenix: Revenue ($m) and AGR (%), 2010-2015
  • Figure 7.7: Zogenix: Revenue ($m) by Type, 2014
  • Figure 7.8: Zogenix: Revenue ($m) by Type, 2015
  • Figure 7.9: 3M: Health Care Historical Revenue ($bn) and AGR (%), 2010-2015
  • Figure 7.10: BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
  • Figure 7.11: BD Medical: Historical Revenue ($bn) and AGR (%), 2010-2015
  • Figure 7.12: Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
  • Figure 7.13: Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
  • Figure 8.1: The Transport Process for a Vaccine

Companies Listed

  • 3M
  • Actavis
  • Activa Brand Products
  • AcuShot
  • Adamis
  • Aktiv-Dry
  • Alkermes
  • Alza
  • Anesiva
  • Antares Pharma
  • Aradigm
  • Astellas Pharma
  • AstraZeneca
  • BD
  • BeadTek
  • Berlex Labs
  • Bespak
  • bioCSL
  • Bioject Medical Technologies
  • Biomedics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb and Somerset Pharmaceuticals
  • Cambridge Consultants
  • CareFusion Corporation
  • CEA-LETI
  • Corium International
  • CosMed
  • Crossject
  • CureVac
  • D'Antonio Consultants International
  • Debiotech
  • Durect
  • Echo Therapeutics
  • Elcam Medical
  • Eli Lilly & Co
  • Endo International
  • Ethical Holdings/Schering
  • Eurojet Medical
  • Ferndale
  • Georgia Institute of Technology
  • Giant Eagle
  • GlaxoSmithKline
  • Glide Pharmaceutical Technologies
  • Hangzhou Hema Medical Equipment
  • Haselmeir GmbH
  • Health-Mor Personal Care
  • Hirtenberger
  • Ichor
  • iHealthNet
  • Immunomic Therapeutics
  • ImmusanT
  • Injex Pharma
  • Inovio Pharmaceuticals
  • Invion
  • Janssen Pharmaceuticals
  • Key Pharmaceuticals
  • Kroger
  • LEO Pharma
  • LTS Lohmann Therapie-Systeme
  • MannKind
  • Mecaplast
  • Meda Pharmaceuticals
  • Medac Pharma
  • Medical International Technologies
  • Medi-Ject
  • MedImmune
  • Merck
  • Merck Serono
  • Micron Biomedical
  • Mylan
  • nanoBioSciences
  • NanoPass
  • Napp Pharmaceuticals
  • National Medical Products
  • Nektar Therapeutics
  • Nemaura
  • Nicobrand Limited
  • Novartis
  • Novo Nordisk
  • Novogyne Pharmaceuticals
  • NuPathe
  • Nycomed
  • Ortho-McNeil
  • Owen MumFord Inc
  • Par Pharmaceutical
  • Parke-Davis
  • Penjet Corporation
  • Pernix
  • Pfizer
  • PharmaJet
  • PKA SoftTouch Corp
  • Procter & Gamble
  • ProStrakan
  • Purdue Pharma
  • Radius Health
  • Rhenovia Pharma
  • Rite Aid
  • Roche
  • Sandoz
  • Sanofi
  • Searle Pharmaceuticals
  • Shire
  • SHL Group AB
  • Shwarz-Pharma
  • Société Nationale des Poudres et Explosifs
  • STADA Arzneimittel AG
  • Stat Medical Devices
  • Takeda
  • Teva
  • The Medical House
  • TheraJect
  • TheraTech
  • Transdermal Specialties
  • Trimeris
  • Trinity-Chiesi
  • UCB Pharma
  • University of California-San Francisco
  • Vaxxas
  • Vetter Pharma
  • Vyteris
  • Watson
  • West Pharmaceuticals
  • Westmount Pharmacy
  • Ypsomed AG
  • Zogenix
  • Zosano
  • Zydus Cadila

Organisations Mentioned in the Report

  • Ankara University
  • Atlanta's Emory University
  • Bill & Melinda Gates Foundation
  • Gwangju Institute of Science and Technology
  • Indian Institute of Science, Bangalore
  • Massachusetts Institute of Technology
  • National University of Singapore
  • Oxford University
  • Seoul National University
  • Shibaura Institute of Technology
  • University of Texas
  • University of Wisconsin's Hospital
Back to Top